FundedIQ
Artificial Intelligence

Caresyntax: Funding, Investors & Team (Sep 2026)

Caresyntax is a digital surgery platform that enables OR teams to predict and improve surgical performance. Its enterprise-grade digital surgery platform delivers insights to improve patient outcomes by using proprietary software and AI to analyze large volumes of video, audio, images, device data, clinical, and operational data in and around the OR. Caresyntax insights help surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. The software is used in more than 4,000 operating rooms worldwide, has supported more than 30,000 surgeons, and improved care for more than 2 million patients.

caresyntax.com LinkedIn Boston, United States 101-250 employees
Analytics Artificial Intelligence Data Visualization Medical Software
Total raised
$230M
Rounds
3
Latest
Undisclosed round
Aug 2024

Caresyntax has raised $230M across 3 funding rounds on record, the most recent an undisclosed round of $100M announced in Aug 2024.

That round is above the $5.7M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.

Caresyntax Company Profile and Key Stats

Total funding raised
$230M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Undisclosed round
$100M in Aug 2024
Employees
101-250
reported band
Headquarters
Boston, United States

Latest funding round on record: Aug 2024.

Caresyntax Funding Rounds

Date
Round
Amount
Undisclosed round
$100M
Series C
$30.0M
Series C
$100M

Caresyntax raised $100M in a Series C announced in Apr 2021.

5 months later, a Series C of $30.0M was announced in Sep 2021.

2.9 years later, an undisclosed round of $100M was announced in Aug 2024.

Caresyntax Founders and Leadership Team

Name
Role
Contact
Dennis Kogan
CEO
Locked

Contact details for the Caresyntax team: 1 of 1 has an email address on file.

Start 14-day free trial →

Caresyntax Funding Compared to Other Artificial Intelligence Startups

Segment
Companies
Median round

Caresyntax's latest round of $100M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Caresyntax in Artificial Intelligence and Boston

Companies Similar to Caresyntax

Cradlewise is an intelligent baby crib that learns from the baby's sleep patterns, spots the first signs of…

Series A $12.0M

Capacity is an AI-powered helpdesk that automates support for customers and employees. Capacity connects…

Series E $54.0M

AfterQuery is an artificial intelligence research and data platform focused on creating high-quality,…

Series B

The future of translation is conversational and Language I/O’s proprietary machine translation optimization…

Undisclosed round $1.5M

Greptile is a platform driven by artificial intelligence that evaluates codebases and improves development…

Undisclosed round $40.0M

Rhealth is a biotechnology company offering hospitals health management solutions utilizing advanced AI…

Equity Crowdfunding $500k
Series A $20.0M

Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…

Series E $156M

Instinct is an artificial intelligence startup developing AI technology.

Series B $250M

Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…

Undisclosed round $15.0M

Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…

Series A $8.0M

Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…

Series A $150M

Caresyntax Funding FAQs

What does Caresyntax do?

Caresyntax is a digital surgery platform that enables OR teams to predict and improve surgical performance. Its enterprise-grade digital surgery platform delivers insights to improve patient outcomes by using proprietary software and AI to analyze large volumes of video, audio, images, device data, clinical, and operational data in and around the OR. Caresyntax insights help surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. The software is used in more than 4,000 operating rooms worldwide, has supported more than 30,000 surgeons, and improved care for more than 2 million patients.

How much funding has Caresyntax raised?

Caresyntax has raised $230M across 3 rounds on record. The most recent is an undisclosed round of $100M announced in Aug 2024.

When did Caresyntax last raise funding?

Caresyntax's most recent funding round on record is an undisclosed round of $100M, announced in Aug 2024.

Who is the CEO of Caresyntax?

Dennis Kogan is listed as CEO at Caresyntax.

Where is Caresyntax headquartered?

Caresyntax is based in Boston, Massachusetts, United States.

How many employees does Caresyntax have?

Caresyntax is in the 101-250 employee band.

How does Caresyntax's funding compare to other Artificial Intelligence startups?

Caresyntax's latest round of $100M is above the $5.7M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.

About FundedIQ's Caresyntax Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Caresyntax is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.